Skip to content

The effects of resistance exercise and training with blood flow restriction on platelet-activating factors

The effects of resistance exercise and training with blood flow restriction on platelet-activating factors in patients with type 2 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130901014540N2
Enrollment
75
Registered
2021-01-04
Start date
2020-04-20
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes. Type 2 diabetes mellitus

Interventions

Intervention 1: Intervention group: Exercise group with limited blood flow: Perform light resistance exercise according to the stated protocol with limited blood flow. Intervention 2: Control group: T

Sponsors

, Shahid Beheshti University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with type 2 diabetes should not have heart disease, including ischemic heart disease including MI, angina, arrhythmia, heart failure, valvular disease, and abnormal ECG. These patients should not take more than two types of medication at the same time and should not take insulin. Patients should not take antiplatelet drugs such as aspirin, NSAIDs, and Clopidogrel, have no history of regular exercise, have not performed resistance training in the last six months, and do not have joint disease.

Exclusion criteria

Exclusion criteria: History of specific infectious and immune diseases, smoking, consumption of alcoholic beverages, dietary supplements and anti-inflammatory drugs, muscle damage and damage to the knee and pelvic joints are the most important factors in the withdrawal of subjects in this research project. Patients with tissue or joint injuries following resistance training are excluded from the research plan.

Design outcomes

Primary

MeasureTime frame
Platelet-activating factors. Timepoint: At the beginning of the study, immediately and 30 minutes after the activity. Method of measurement: Flow cytometry is used to measure P-selectin, GpIIb / IIIa.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactelahe malekyian

, Shahid Beheshti University

malekyian.e@gmail.com+98 31 5591 2892

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026